Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors

W. de Riese, E. B. Walker, C. de Riese, Thomas Ulbright, W. N. Crabtree, J. Messemer, J. A. Jones, A. Hinkel, Richard Foster, J. P. Donohue, T. Senge

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Current clinical staging, which includes the use of serum tumor markers and imaging techniques, fails to identify the 30-40% of clinical stage I (CS I) nonseminomatous germ cell testicular tumor (NSGCT) patients who have occult metastatic disease. Therefore, there is a real clinical need to evaluate new biological parameters of the primary tumor that might be useful as predictors of occult metastatic disease. This study was undertaken to compare quantitative DNA measurements by flow cytometry and image analysis in CS I NSGCT, and to analyze the relevance of these parameters for predicting occult lymph node involvement. Different blocks of formalin-fixed, paraffin-embedded NSGCTs of 62 CS I patients who underwent retroperitoneal lymph node dissection between 1985 and 1989 were prepared according to the Hedley technique, and analyzed by quantitative cytometry. Thirty-six (58.1%) patients had histologically proven lymph node involvement (pathological stage II), whereas 26 (41.9%) patients (pathological stage I) had neither lymph node metastases according to retroperitoneal lymph node dissection (RPLND) specimens nor tumor recurrence during follow-up. Concordant results were found in 76.5% of the samples by both cytometric techniques. For flow cytometry, the percentages of aneuploid cells in the S- and the G2M+S-phase were the most robust predictive parameters for lymph node involvement, whereas for image analysis the 5c exceeding rate (5cER) had the most predictive significance. Based on the experience obtained in this study, both cytometric techniques provide additional information on tumor aggressiveness that might be useful in therapeutic selection of early stage NSGCT patients for either RPLND or surveillance only.

Original languageEnglish
Pages (from-to)213-220
Number of pages8
JournalUrological Research
Volume22
Issue number4
DOIs
StatePublished - Jul 1994

Fingerprint

Flow Cytometry
Lymph Node Excision
Lymph Nodes
DNA
Neoplasms
Aneuploidy
Tumor Biomarkers
S Phase
Paraffin
Formaldehyde
Biomarkers
Nonseminomatous germ cell tumor
Neoplasm Metastasis
Recurrence
Therapeutics

Keywords

  • DNA content
  • Flow cytometry
  • Image analysis
  • Testicular cancer

ASJC Scopus subject areas

  • Urology

Cite this

Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors. / de Riese, W.; Walker, E. B.; de Riese, C.; Ulbright, Thomas; Crabtree, W. N.; Messemer, J.; Jones, J. A.; Hinkel, A.; Foster, Richard; Donohue, J. P.; Senge, T.

In: Urological Research, Vol. 22, No. 4, 07.1994, p. 213-220.

Research output: Contribution to journalArticle

de Riese, W, Walker, EB, de Riese, C, Ulbright, T, Crabtree, WN, Messemer, J, Jones, JA, Hinkel, A, Foster, R, Donohue, JP & Senge, T 1994, 'Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors', Urological Research, vol. 22, no. 4, pp. 213-220. https://doi.org/10.1007/BF00541895
de Riese, W. ; Walker, E. B. ; de Riese, C. ; Ulbright, Thomas ; Crabtree, W. N. ; Messemer, J. ; Jones, J. A. ; Hinkel, A. ; Foster, Richard ; Donohue, J. P. ; Senge, T. / Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors. In: Urological Research. 1994 ; Vol. 22, No. 4. pp. 213-220.
@article{018d15b581814795908ad3dcf4db21b1,
title = "Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors",
abstract = "Current clinical staging, which includes the use of serum tumor markers and imaging techniques, fails to identify the 30-40{\%} of clinical stage I (CS I) nonseminomatous germ cell testicular tumor (NSGCT) patients who have occult metastatic disease. Therefore, there is a real clinical need to evaluate new biological parameters of the primary tumor that might be useful as predictors of occult metastatic disease. This study was undertaken to compare quantitative DNA measurements by flow cytometry and image analysis in CS I NSGCT, and to analyze the relevance of these parameters for predicting occult lymph node involvement. Different blocks of formalin-fixed, paraffin-embedded NSGCTs of 62 CS I patients who underwent retroperitoneal lymph node dissection between 1985 and 1989 were prepared according to the Hedley technique, and analyzed by quantitative cytometry. Thirty-six (58.1{\%}) patients had histologically proven lymph node involvement (pathological stage II), whereas 26 (41.9{\%}) patients (pathological stage I) had neither lymph node metastases according to retroperitoneal lymph node dissection (RPLND) specimens nor tumor recurrence during follow-up. Concordant results were found in 76.5{\%} of the samples by both cytometric techniques. For flow cytometry, the percentages of aneuploid cells in the S- and the G2M+S-phase were the most robust predictive parameters for lymph node involvement, whereas for image analysis the 5c exceeding rate (5cER) had the most predictive significance. Based on the experience obtained in this study, both cytometric techniques provide additional information on tumor aggressiveness that might be useful in therapeutic selection of early stage NSGCT patients for either RPLND or surveillance only.",
keywords = "DNA content, Flow cytometry, Image analysis, Testicular cancer",
author = "{de Riese}, W. and Walker, {E. B.} and {de Riese}, C. and Thomas Ulbright and Crabtree, {W. N.} and J. Messemer and Jones, {J. A.} and A. Hinkel and Richard Foster and Donohue, {J. P.} and T. Senge",
year = "1994",
month = "7",
doi = "10.1007/BF00541895",
language = "English",
volume = "22",
pages = "213--220",
journal = "Urolithiasis",
issn = "2194-7228",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors

AU - de Riese, W.

AU - Walker, E. B.

AU - de Riese, C.

AU - Ulbright, Thomas

AU - Crabtree, W. N.

AU - Messemer, J.

AU - Jones, J. A.

AU - Hinkel, A.

AU - Foster, Richard

AU - Donohue, J. P.

AU - Senge, T.

PY - 1994/7

Y1 - 1994/7

N2 - Current clinical staging, which includes the use of serum tumor markers and imaging techniques, fails to identify the 30-40% of clinical stage I (CS I) nonseminomatous germ cell testicular tumor (NSGCT) patients who have occult metastatic disease. Therefore, there is a real clinical need to evaluate new biological parameters of the primary tumor that might be useful as predictors of occult metastatic disease. This study was undertaken to compare quantitative DNA measurements by flow cytometry and image analysis in CS I NSGCT, and to analyze the relevance of these parameters for predicting occult lymph node involvement. Different blocks of formalin-fixed, paraffin-embedded NSGCTs of 62 CS I patients who underwent retroperitoneal lymph node dissection between 1985 and 1989 were prepared according to the Hedley technique, and analyzed by quantitative cytometry. Thirty-six (58.1%) patients had histologically proven lymph node involvement (pathological stage II), whereas 26 (41.9%) patients (pathological stage I) had neither lymph node metastases according to retroperitoneal lymph node dissection (RPLND) specimens nor tumor recurrence during follow-up. Concordant results were found in 76.5% of the samples by both cytometric techniques. For flow cytometry, the percentages of aneuploid cells in the S- and the G2M+S-phase were the most robust predictive parameters for lymph node involvement, whereas for image analysis the 5c exceeding rate (5cER) had the most predictive significance. Based on the experience obtained in this study, both cytometric techniques provide additional information on tumor aggressiveness that might be useful in therapeutic selection of early stage NSGCT patients for either RPLND or surveillance only.

AB - Current clinical staging, which includes the use of serum tumor markers and imaging techniques, fails to identify the 30-40% of clinical stage I (CS I) nonseminomatous germ cell testicular tumor (NSGCT) patients who have occult metastatic disease. Therefore, there is a real clinical need to evaluate new biological parameters of the primary tumor that might be useful as predictors of occult metastatic disease. This study was undertaken to compare quantitative DNA measurements by flow cytometry and image analysis in CS I NSGCT, and to analyze the relevance of these parameters for predicting occult lymph node involvement. Different blocks of formalin-fixed, paraffin-embedded NSGCTs of 62 CS I patients who underwent retroperitoneal lymph node dissection between 1985 and 1989 were prepared according to the Hedley technique, and analyzed by quantitative cytometry. Thirty-six (58.1%) patients had histologically proven lymph node involvement (pathological stage II), whereas 26 (41.9%) patients (pathological stage I) had neither lymph node metastases according to retroperitoneal lymph node dissection (RPLND) specimens nor tumor recurrence during follow-up. Concordant results were found in 76.5% of the samples by both cytometric techniques. For flow cytometry, the percentages of aneuploid cells in the S- and the G2M+S-phase were the most robust predictive parameters for lymph node involvement, whereas for image analysis the 5c exceeding rate (5cER) had the most predictive significance. Based on the experience obtained in this study, both cytometric techniques provide additional information on tumor aggressiveness that might be useful in therapeutic selection of early stage NSGCT patients for either RPLND or surveillance only.

KW - DNA content

KW - Flow cytometry

KW - Image analysis

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=0027973075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027973075&partnerID=8YFLogxK

U2 - 10.1007/BF00541895

DO - 10.1007/BF00541895

M3 - Article

C2 - 7871632

AN - SCOPUS:0027973075

VL - 22

SP - 213

EP - 220

JO - Urolithiasis

JF - Urolithiasis

SN - 2194-7228

IS - 4

ER -